Ask AI
ProCE Banner Series

TROP2-Directed Therapy in Metastatic Triple-Negative Breast Cancer: Expert Insights on Patient Selection, Sequencing, and Practical Management

Join this SABCS 2026 satellite symposium for expert, case-based insights on integrating TROP2-directed ADCs into mTNBC care. Faculty will examine established approvals, evolving phase III evidence, and recently approved indications to help inform patient selection, treatment sequencing, and practical toxicity management.

This symposium is sponsored by Clinical Care Options, LLC dba Decera Clinical Education and supported by a grant from Gilead Sciences, Inc. This is not an official program of the San Antonio Breast Cancer Symposium®. 

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This educational activity is intended for oncologists and other oncology healthcare professionals directly involved in the care of patients with mTNBC, including nurse practitioners, physician associates, oncology pharmacists, and oncology nurses.

All Events

TROP2-Directed Therapy in Metastatic Triple-Negative Breast Cancer: Expert Insights on Patient Selection, Sequencing, and Practical Management

Upcoming Events

December

10

2026

7:00 PM - 9:00 PM Central Time (CT)

In-person

San Antonio Marriott Rivercenter, 101 Bowie Street, San Antonio, Texas 78295

7:30 PM - 9:00 PM Central Time (CT)

Virtual

Topics

Breast Cancers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in in applying current and emerging evidence to patient selection, sequencing, and toxicity management for TROP2-directed ADCs in mTNBC.

Target Audience
This educational activity is intended for oncologists and other oncology healthcare professionals directly involved in the care of patients with mTNBC, including nurse practitioners, physician associates, oncology pharmacists, and oncology nurses.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Differentiate established standards of care from emerging evidence-based treatment strategies in mTNBC and evolving role of TROP2-directed ADCs

  • Interpret key data and evolving clinical guidance to inform appropriate use of TROP2-directed ADCs across distinct mTNBC cancer populations

  • Apply patient- and disease-specific factors to individualize treatment selection and sequencing across the mTNBC continuum

  • Implement proactive, multidisciplinary monitoring and management strategies for clinically significant toxicities associated with TROP2-directed ADCs

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: xxxx

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Title: A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191